EMI of 0.25% Roadyes-treated red clay after failure. حسب Quan Shen (37564)

الموضوعات:

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... حسب Mingee Choi (15250732)

الموضوعات:

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. حسب Mingee Choi (15250732)

الموضوعات:

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. حسب Mingee Choi (15250732)

الموضوعات:

General information of patient who diagnosis insomnia disorder (N = 518,119). حسب Mingee Choi (15250732)

الموضوعات:

Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. حسب Mingee Choi (15250732)

الموضوعات:

Treatment at first diagnosis of insomnia disorder (%). حسب Mingee Choi (15250732)

الموضوعات:

Temporal dynamics of Sox10-E1 and Sox10-E2 along the OL lineage. حسب Hongjoo An (21703199)

الموضوعات:

The raw data for Fig 4. حسب Hongjoo An (21703199)

الموضوعات:

CRISPRi interrogation of the <i>Sox10</i> ECs. حسب Hongjoo An (21703199)

الموضوعات:

Cell type specificity of Sox10-E1 and Sox10-E2. حسب Hongjoo An (21703199)

الموضوعات:

Five <i>Sox10</i> ECs. حسب Hongjoo An (21703199)

الموضوعات:

The raw data for S2 Fig. حسب Hongjoo An (21703199)

الموضوعات:

TAD analysis for <i>Sox10.</i> حسب Hongjoo An (21703199)

الموضوعات:

Effect of Sox10-E1 and Sox10-E2 on the expression of <i>Pick1.</i> حسب Hongjoo An (21703199)

الموضوعات:

The raw data for Fig 5B. حسب Hongjoo An (21703199)

الموضوعات:

The raw data for Fig 8A. حسب Hongjoo An (21703199)

الموضوعات:

The raw data for Fig 6. حسب Hongjoo An (21703199)

الموضوعات:

The raw data for S4 Fig. حسب Hongjoo An (21703199)

الموضوعات: